Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial


Waidmann O., Abou-Alfa G. K., Meyer T., Cheng A., El-Khoueiry A. B., Rimassa L., ...Daha Fazla

ONCOLOGY RESEARCH AND TREATMENT, cilt.41, ss.254, 2018 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 41
  • Basım Tarihi: 2018
  • Dergi Adı: ONCOLOGY RESEARCH AND TREATMENT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.254
  • Trakya Üniversitesi Adresli: Evet